COMP <GO>
ZJYL vs ENOV // RETURN ON INVESTED CAPITAL (ROIC)
JIN MEDICAL INTERNATIONAL LTD. (Class A) (NASDAQ) VS. Enovis Corporation (NYSE) • 15-METRIC TALLY: ZJYL 3
— ENOV 5
■ METRIC PARITY
LAST: $2.20 (-6.38%) • MKT CAP: $371.8M
roic
—
LAST: $20.62 (+3.57%) • MKT CAP: $1.15B
roic
-32.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZJYL VS. ENOV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZJYL | ENOV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.20% | 59.80% | -30.60 | ENOV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | — | -32.70% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 47.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.27% | 1.51% | -2.78 | ENOV | /fcf-yield <GO> |
| Operating Margin | 2.90% | -50.00% | +52.90 | ZJYL | /operating-margins <GO> |
| Net Profit Margin | 5.80% | -52.70% | +58.50 | ZJYL | /net-margins <GO> |
| Revenue Growth (YoY) | -12.00% | 6.70% | -18.70 | ENOV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | ENOV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.0 | 48.2 | +8.80 | ZJYL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $371.8M | $1.15B | -$776.4M | ENOV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZJYL REV | ENOV REV | ZJYL GROSS % | ENOV GROSS % | ZJYL FCF | ENOV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.7M | $2.25B | 29.2% | 59.8% | -$3.7M | $19.9M |
| FY 2024 | $23.5M | $2.11B | 40.4% | 56.0% | -$1.4M | -$67.2M |
| FY 2023 | $19.8M | $1.71B | — | — | $3.1M | $135.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZJYL // BETA —
ENOV // BETA —